The significantly elevated insulin levels overly stimulate IGF-1 and both the Insr and the IGF-1R, resulting in increased survival of pre-malignant cells, heightened cancer cell proliferation, and resistance to apoptosis. The gene discussed is INS; the disease is cancer.